Literature DB >> 16837509

High-calcium vs high-phosphate intake and small artery tone in advanced experimental renal insufficiency.

Peeter Kööbi1, Tuija I Vehmas, Pasi Jolma, Jarkko Kalliovalkama, Meng Fan, Onni Niemelä, Heikki Saha, Mika Kähönen, Pauli Ylitalo, Jaana Rysä, Heikki Ruskoaho, Ilkka Pörsti.   

Abstract

BACKGROUND: Disturbed calcium-phosphorus balance significantly contributes to uraemic changes in large arteries. We examined the influences of high-calcium and high-phosphate intake on small artery tone in experimental renal insufficiency.
METHODS: Sixty-five rats were assigned to 5/6 nephrectomy (NTX) or sham operation. After 15 week disease progression, NTX rats were given high-calcium (3%), high-phosphate (1.5%) or control diet (0.3% calcium, 0.5% phosphate) for 12 weeks. Then isolated segments of small mesenteric arteries were studied using wire and pressure myographs.
RESULTS: Subtotal nephrectomy reduced creatinine clearance by 60% and increased parathyroid hormone (PTH) and phosphate 12-fold and 2.7-fold, respectively. High-phosphate intake further elevated PTH and phosphate (33-fold and 5.5-fold, respectively), while the calcium diet suppressed them (to 3.5 and 62% vs sham, respectively). Ventricular B-type natriuretic peptide synthesis was increased, and blood pressure was 27 and 18 mmHg higher in NTX rats on control and phosphate diet, respectively, than in calcium-fed rats. Vasorelaxation to acetylcholine was impaired by approximately 50% in uraemic rats, and was further deteriorated by high-phosphate intake, whereas the calcium diet improved endothelium-mediated relaxation via nitric oxide and potassium channels. Small arteries of all NTX groups featured eutrophic inward remodelling: wall-to-lumen ratio was increased 1.3-fold without change in cross-sectional area.
CONCLUSION: High-phosphate intake had a detrimental influence on secondary hyperparathyroidism and vasodilatation, whereas high-calcium intake reduced blood pressure and PTH, alleviated volume overload and improved vasorelaxation in experimental renal insufficiency. Therefore, alterations in the calcium-phosphorus balance can significantly modulate small artery tone during impaired kidney function.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16837509     DOI: 10.1093/ndt/gfl270

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  6 in total

1.  High Salt Upregulates Ca2+-Sensing Receptor Expression and Ca2+-Induced Relaxation of Contracted Mesenteric Arteries from Dahl Salt-Sensitive Rats.

Authors:  Lakeesha E Bridges; Cicely L Williams; Emmanuel M Awumey
Journal:  J Pharmacol Exp Ther       Date:  2022-03-19       Impact factor: 4.030

Review 2.  The connection between dietary phosphorus, cardiovascular disease, and mortality: where we stand and what we need to know.

Authors:  Orlando M Gutiérrez
Journal:  Adv Nutr       Date:  2013-11-06       Impact factor: 8.701

Review 3.  CKD-MBD: impact on management of kidney disease.

Authors:  Hiroaki Ogata; Fumihiko Koiwa; Eriko Kinugasa; Tadao Akizawa
Journal:  Clin Exp Nephrol       Date:  2007-12-21       Impact factor: 2.801

4.  Computer-assisted imaging algorithms facilitate histomorphometric quantification of kidney damage in rodent renal failure models.

Authors:  Marcin Klapczynski; Gerard D Gagne; Sherry J Morgan; Kelly J Larson; Bruce E Leroy; Eric A Blomme; Bryan F Cox; Eugene W Shek
Journal:  J Pathol Inform       Date:  2012-04-28

5.  Dietary phosphate restriction ameliorates endothelial dysfunction in adenine-induced kidney disease rats.

Authors:  Tan Vu Van; Eriko Watari; Yutaka Taketani; Tomoyo Kitamura; Asuka Shiota; Terumi Tanaka; Ayako Tanimura; Nagakatsu Harada; Yutaka Nakaya; Hironori Yamamoto; Ken-Ichi Miyamoto; Eiji Takeda
Journal:  J Clin Biochem Nutr       Date:  2012-01-28       Impact factor: 3.114

6.  Ergocalciferol improves endothelial vasodilatory and vasoconstrictor function in an in vivo model of mild uraemia.

Authors:  Gavin Dreyer; Julius Kieswich; Steven Harwood; Amrita Ahluwalia; Muhammad M Yaqoob
Journal:  Biosci Rep       Date:  2019-12-20       Impact factor: 3.840

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.